. 2021 Jul 28;8(4):589–601. doi: 10.1007/s40801-021-00262-7

Table 5.

Comparison of adverse drug reaction (ADR) frequencies for parenteral anthroposophic medicinal product (AMP) with other studies

Study	Design	Country, period	ADRs		ADRs/MDADs^a
Study	Design	Country, period	N	MDAD^a
This study	PV database	DE, 2010–2017	1539	82.63	18.85
Jong et al. [26]	PV database	DE, 2007–2009	172	6.89	24.98
Hamre (EvaMed) [7]	Prospective cohort	DE, 2001–2010	28	0.37	75.65

PV pharmacovigilance, DE Germany, MDADs maximum daily administration doses sold

^a× 1 million